Negative consequences of glycation. (Q33849766)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Negative consequences of glycation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

author name string

M Brownlee

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

issue

2 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

9-13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Nonenzymatic glycation of peripheral and central nervous system proteins in experimental diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Non-enzymatic glycation of peripheral nerve proteins in human diabetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Glucosylation of human haemoglobin a in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Pathways of Formation of Glycoxidation Products during Glycation of Collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Evidence for glucose-mediated covalent cross-linking of collagen after glycosylation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Glycation induces expansion of the molecular packing of collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. Role in the in situ formation of immune complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

In vitro glycation of glomerular basement membrane alters its permeability: a possible mechanism in diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

α-Lipoic Acid in the Treatment of Diabetic Peripheral and Cardiac Autonomic Neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Modification of DNA by reducing sugars: a possible mechanism for nucleic acid aging and age-related dysfunction in gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Modification of DNA by glucose 6-phosphate induces DNA rearrangements in an Escherichia coli plasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Elevated glucose 6-phosphate levels are associated with plasmid mutations in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Transposition of an Alu-containing element induced by DNA-advanced glycosylation endproducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Identification of N2-(1-carboxyethyl)guanine (CEG) as a guanine advanced glycosylation end product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

The reaction of methylglyoxal with aminoguanidine under physiological conditions and prevention of methylglyoxal binding to plasma proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Secondary intervention with aminoguanidine retards the progression of diabetic retinopathy in the rat model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0026-0495(00)80078-5

10.1016/S0026-0495(00)80078-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10693913 AND SRC:MED&resulttype=core&format=json

4 November 2019

1 reference